The Enterprise Value as of December 2025 (TTM) for Valerio Therapeutics S.A. (ALVIO.PA) is 69.60M

According to Valerio Therapeutics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 69.60M. This represents a change of 179.07% compared to the average of 24.94M of the last 4 quarters.

Valerio Therapeutics S.A. (ALVIO.PA) Historical Enterprise Value (quarterly & annually)

How has ALVIO.PA Enterprise Value performed in the past?

The mean historical Enterprise Value of Valerio Therapeutics S.A. over the last ten years is 10.03M. The current 69.60M Enterprise Value has changed 69.28% with respect to the historical average. Over the past ten years (40 quarters), ALVIO.PA's Enterprise Value was at its highest in in the December 2023 quarter at 27.63M. The Enterprise Value was at its lowest in in the December 2014 quarter at -42073545.88.

Valerio Therapeutics S.A. (ALVIO.PA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Valerio Therapeutics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Valerio Therapeutics S.A. (ALVIO.PA) Average Enterprise Value

How has ALVIO.PA Enterprise Value performed in the past?

The current Enterprise Value of Valerio Therapeutics S.A. (ALVIO.PA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Valerio Therapeutics S.A. (ALVIO.PA) Enterprise Value vs. Peers

How is ALVIO.PA’s Enterprise Value compared to its peers?

Valerio Therapeutics S.A.’s Enterprise Value is greater than Nicox S.A. (31.80M), greater than Novacyt S.A. (9.46M), greater than GenSight Biologics S.A. (36.30M), greater than Advicenne S.A. (42.80M), greater than Implanet S.A. (29.02M), greater than genOway S.A. (35.61M), greater than Poxel S.A. (57.15M), greater than Theraclion S.A. (25.83M), greater than Diagnostic Medical Systems S.A. (43.36M), greater than Valbiotis S.A. (10.89M),

Build a custom stock screener for Valerio Therapeutics S.A. (ALVIO.PA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valerio Therapeutics S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Valerio Therapeutics S.A. (ALVIO.PA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Valerio Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.